Genetic Variations Impact Warfarin Doses For African Americans

A common genetic variation that can impact the therapeutic dose of the blood-thinning drug warfarin among African Americans has been found, according to a new report in The Lancet. The finding revealed that people of African ancestry who have the rs12777823 variant require a notably lower dose of warfarin to achieve all the advantages, compared to those without this single-nucleotide polymorphism (SNP)...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Blood / Hematology Source Type: news